TNF inhibitors prevent complications in kids with Crohn’s disease: Study recommends them as first-line therapies

Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of Crohn’s disease.
Facebook Comments